Professional Documents
Culture Documents
DOC1 TRN Brochure
DOC1 TRN Brochure
RE-ESTABLISHING
Burst Mode 1, 2 and 3 pulses per burst, selectable
Electrical Requirements 100–240 VAC, 50/60 Hz, <800 VA
Spot Size 8 μm
Offset (Anterior & Posterior) 0, -500 to +2000 μm Weight 27.5 kg, 60.6 lbs (laser only)
YOUR PATIENT’S BASELINE, Aiming Beam Dual green 515 nm, adjustable intensity Dimensions (HxWxD)
Standard Accessories
57 x 75 x 44 cm, 23 x 30 x 18 inches (laser only)
Total Solution™ table, safety glasses,
Green aiming beam & patient fixation (6) Reardon G, Kotak S, Objective assessment of compliance and
persistence among patients treated for glaucoma and ocular
hypertension: a systematic review. Epub 2011 Sep 23.
Artwork : www.overscan.fr
Trabeculoplasty in Medication-Naive Open-Angle
Glaucoma and Ocular Hypertension during the LiGHT Trial.
beam provides the highest degree of visual contrast Ophthalmology. 2020 Apr;127(4):467-476. doi: 10.1016/j.
ophtha.2019.10.023. Epub 2019 Oct 30. PMID: 32005561.
for YAG laser procedures, resulting in easier target (8) European Glaucoma Society Terminology and Guidelines
visualization and more proficient treatment delivery. for Glaucoma, 5th Edition. Br J Ophthalmol. 2021
Jun;105(Suppl 1):1-169. doi: 10.1136/bjophthalmol-2021-
egsguidelines. PMID: 34675001.
Precision incision
Ellex’s proprietary YAG laser cavity with Tango Reflex™
Neo, delivers a four nanosecond Ultra-Gaussian pulse
0805
at high peak power, typically achieving the industry’s
lowest optical breakdown of 1.4 mJ in air 4. The hyper- Manufacturer Headquarters
Ellex Medical Pty Ltd Lumibird Medical ELLEX
efficient laser profile designed by Ellex generates far 3-4 Second Avenue 1, Rue du Bois Joli - CS40015 A brand of
superior and precise photodisruption of sensitive Mawson Lakes, SA 5095 Australia 63808 Cournon d’Auvergne – France
Image courtesy of Karl Brasse, MD Tel: +61 (0)8 7074 8200 Tel: +33 (0)4 73 745 745
ocular tissues and better patient outcomes. www.lumibirdmedical.com
ISO 13485 : 2016
S
E N T IN YA G & SLT MODE
XIS TREATM
ON OR OFF-A
E L L E X, A B R A
ND O F LU M IB IR D MEDICAL
GLAUCOMA
TREATMENT
Imprint™
A real-time view of
MODE and ENERGY
settings.
Iridotomy
Ellex Second Generation Reflex™
Technology Ellex’s discrete Imprint™ - dynamic Heads-up- For the YAG treatment of angle closure
display, combined with full functional control of glaucoma, Tango Reflex™ Neo with
With mode-specific mirror positioning and energy settings and laser delivery from a dual burst mode provides double or triple
True Coaxial Illumination™, Ellex’s second- function joystick, absolutely streamlines laser laser impact for more efficient creation
generation Reflex™ design allows for procedures. No distractions, complete focus, of a laser peripheral iridotomy within
titratable illumination from full, to partial TOTAL CONTROL. an iris crypt.
or no red-reflex, giving complete spatial
integrity and excellent contrast of the
posterior capsule and other important ocular
structures.
Active Cooling Cavity Technology
The active cooIing cavity design of the Tango
Exceptional Visualization Reflex™ Neo ensures laser stability and
repeatability over even the lengthiest treatment,
Featuring Ellex proprietary Reflex™ delivering consistent laser pulses at up to 4 Hz,
FOUR TIMES PER SECOND, ensuring precise
LIGHT STUDY IN FIGURES5
Technology, Tango Reflex™ Neo binocular
image, both on and off-axis, combined with dosage with every laser pulse. SLT
titratable illumination, allows high-fidelity
visualization of posterior capsule and other 652 For the treatment of primary open angle
important ocular structures. This critical PATIENTS RANDOMLY ASSIGNED TO SLT glaucoma and ocular hypertension, Tango
design feature improves clarity overall and (329 PATIENTS) OR EYE DROPS Reflex™ Neo incorporates Ellex’s proprietary
increases certainty when performing laser (323 PATIENTS). SLT technology providing superior energy
treatments. control, an homogenous sharp-edged aiming
beam and the industry’s fastest laser firing
rate of up to 4 Hz - FOUR SHOTS PER SECOND.
>74.2%
74.2% • Compliance with medication is key and can
OF SLT PATIENTS REACHED TARGET IOP
be extremely problematic6.
AND WERE DROP-FREE AT 36 MONTHS.
• SLT takes compliance out of the patient’s
hands and is a REPEATABLE laser therapy7.
remote diagnostics.